Stay updated with breaking news from Iological Marker. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
New research shows that ctDNA clearance following neoadjuvant treatment of muscle-invasive urothelial cancer can help predict response to therapy and the risk for relapse.
A recent study validated the predictive biomarker's effectiveness in guiding treatment decisions for diverse groups.
In healthy young adults, vitamin D levels is inversely correlated with cardiovascular disease risk factors.
Ashwin Ananthakrishnan, MD, lead author of the new AGA guidelines, discussed using biomarkers over endoscopy in monitoring treatment response among specific types of CD.
To take advantage of the latest targeted therapies in gastroesophageal cancer, physicians needed to identify patients who will benefit, but biomarker testing in this population continued to lag.